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Abstract
 
The differentiation of CD4
 
  
 
CD8
 
  
 
double positive (DP) thymocytes requires the irreversible
choice between two alternative lineages, distinguished by the mutually exclusive expression of
either CD4 or CD8. Differentiating DP cells transiently down-regulate both CD4 and CD8,
and this has complicated the debate whether the mechanism of CD4/CD8 lineage choice is in-
structive, stochastic/selective, or more complex in nature. Using fluorescence in situ hybridization,
we show that the stable silencing of coreceptor loci, and ultimately lineage choice, is predicted
by the spatial repositioning of coreceptor alleles to centromeric heterochromatin domains.
These data provide evidence that lineage-specific developmental programs are established early
during the transition from the DP to the single positive stage.
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Introduction
 
As cells make developmental choices, their genomes are
modified to reflect their previous developmental history as
well as their developmental potential (1). This occurs at an
epigenetic level, rather than at the level of primary nu-
cleotide sequence. Epigenetic modifications include DNA
(CpG) methylation (2), the packaging of DNA in chroma-
tin, the posttranslational modification of chromatin proteins
(3), and the spatial partitioning of gene loci into transcrip-
tionally permissive and repressive domains within the nucleus
(4, 5). Silent, but not active, gene loci are often found in
close proximity to centromeric heterochromatin in acti-
vated B cells (4, 6). In double positive (DP) thymocytes,
the spatial repositioning of RAG and Tdt loci to pericentric
heterochromatin marks their stable silencing in response to
TCR engagement (6) and is associated with the spreading
of repressive histone modifications over an extended region
of the Tdt locus (7). Centromeric repositioning does not
occur during transient RAG and Tdt silencing in the DP
cell line VL3-3M2 (6), where repressive histone modifica-
tions remain confined to the Tdt promoter region (7).
These data suggest that for the Tdt locus at least, centro-
meric repositioning is part of a concerted program of epi-
genetic events that stabilize gene silencing. Proximity to
centromeres in cis (as a result of chromosomal transloca-
tions or the centromeric integration of transgenes) can result
in gene silencing (8), and the recruitment of chromatin do-
mains to centromeric heterochromatin in trans has been
mechanistically linked to gene silencing by the requirement
for polycomb proteins, histone methyltransferases, and het-
erochromatin binding proteins in 
 
Drosophila
 
 (9, 10).
The development of T cells in the thymus is understood
in considerable detail and provides a useful model for cellular
commitment and differentiation in metazoans. Commitment
and differentiation of CD4
 
  
 
CD8
 
  
 
DP thymocytes to the
CD4 or the CD8 lineage is triggered by TCR engagement
and proceeds via a series of intermediate (DP
 
lo 
 
and CD4
 
 
 
CD8
 
lo
 
) stages (11, 12). Transiently reduced expression of
CD4 and CD8 RNA and protein occurs in thymocytes
en route to either lineage and is not predictive of lineage
fate (12–19). This has added complexity to the debate as
to whether thymocyte lineage choice operates instructive
or stochastic/selective mechanisms, or results from cellular
computations of signal strength and duration (11, 12).
Here, a functional appraisal of thymocyte lineage com-
mitment and developmental potential is combined with a
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detailed analysis of CD4 and CD8 locus position (4) in
transitional thymocyte subsets. We show that lineage choice
is anticipated by the repositioning of coreceptor alleles to
centromeric heterochromatin domains. Centromeric repo-
sitioning is progressive, developmentally regulated, and se-
lectively affects coreceptor loci that are subject to stable si-
lencing. Our results provide evidence that lineage-specific
developmental programs are implemented at an early stage
of DP to single positive (SP) differentiation.
 
Materials and Methods
 
Mouse Strains, Cell Sorting, and Cell and Organ Culture.
 
OT-I
(20) and AND (21) TCR transgenic mice on a RAG-1
 
o/o 
 
(22)
background were used as sources of MHC class I– (K
 
b
 
) or II–
(E
 
k
 
/A
 
b
 
) selected thymocytes, respectively. A
 
 
 
o/o 
 
(23), 
 
 
 
2m
 
o/o
 
(24), or Tap1
 
o/o 
 
(25) thymi were used as sources of thymocytes
with a wild-type TCR repertoire selected by MHC class I or II,
respectively. MHC
 
o/o 
 
(A
 
 
 
o/o 
 
 
 
2m
 
o/o
 
) thymocytes were used as
the source of MHC-naive thymocytes. All procedures involving
animals were approved by the Home Office, UK. Thymocytes
were stained with CD4-PE/Cy5, CD8a-PE (Caltag Laborato-
ries), and in some experiments CD69-FITC (BD Biosciences),
and sorted on a FACS DIVA (Becton Dickinson) and subjected
to fluorescence in situ hybridization (FISH; see below), or re-
aggregated with MHC
 
o/o 
 
or C57BL/10 (H-2
 
b
 
) thymic stroma
as described previously (26). Where indicated, CD3/CD4- or
CD3/CD3-bispecific antibodies (27) were added to the cultures
and thymocyte suspensions were stained with CD4-PE/Cy5 or
-APC, CD8-PE or -FITC, and analyzed on a FACSCalibur
(Becton Dickinson). Thymocytes were stained with CD4-PE/
Cy5, CD5-PE (Caltag Laboratories), and sorted for FISH analy-
sis after 18 h.
 
FISH.
 
Three-dimensional (3-D) FISH was performed as de-
scribed previously (4). For FISH involving heat denaturation,
cells were fixed to coverslips in 4% paraformaldehyde/PBS for 10
min, permeabilized in 0.2% Triton X-100/PBS for 12 min,
heated to 95
 
 
 
C for 8 min in the presence of probes in hybridiza-
tion mix, and placed on ice for 2 min. Hybridization and probe
detection were performed as described previously (4). Probes for
 
  
 
satellite repeats, CD4 (p7
 
 
 
.3.1), CD8 (CD8
 
 
 
-1), and TCR
 
 
 
(32.1w7) were provided by N. Dillon (Imperial College, Lon-
don, UK), A. Rahemtulla (Imperial College, London, UK), D.
Kioussis (National Institute for Medical Research, London, UK),
and M. Malissen (Centre d’Immunologie de Marseille-Luminy,
Marseille, France). Samples were counterstained with DAPI and
analyzed on a Leica TCS-4D or SP2 confocal microscope. Dis-
tance measurements were taken with Volocity software (http://
www.improvision.com).
 
Online Supplemental Material.
 
A description of distance mea-
surements (Fig. S1) and data obtained in the coreceptor reexpres-
sion assay (Fig. 2) are available at http://www.jem.org/cgi/content/
full/jem.20041127/DC1.
 
Results
 
Coreceptor Locus Repositioning during Lineage Commitment
and Differentiation.
 
To ask if nuclear organization is pre-
dictive of lineage choice, we sorted thymocyte populations
in transit from the DP to the SP stage from mice where
thymocyte differentiation is driven either by MHC class I
or II and the ultimate lineage outcome is known. DP
 
hi
Figure 1. Developmental regulation of coreceptor
locus position. (A) The position of CD8 alleles
(green) relative to   satellite repeats (red) was ana-
lyzed by 3-D FISH and defined as associated, con-
strained, or not associated as detailed in Fig. S1. Bar,
2  m. (B) The percentage of cells with centromeri-
cally positioned CD8 loci in thymocyte subsets iso-
lated from MHCo/o, class I–deficient, AND TCR
transgenic, and OT-I TCR transgenic mice. For
MHCo/o, AND, and OT-I thymocyte subsets, the
position of CD4 alleles was also evaluated. 
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CD69
 
 
 
, DP
 
lo 
 
CD69
 
 
 
, CD4
 
  
 
CD8
 
lo
 
, and CD4 SP thy-
mocyte populations from MHC class I–deficient mice
(Tap1
 
o/o 
 
or 
 
 
 
2m
 
o/o
 
) and AND TCR (RAG-1
 
o/o 
 
H2
 
b
 
)
transgenic mice were subjected to 3-D FISH, which pre-
serves the spatial relationship between proteins and DNA
in the nucleus (4). The position of CD4 and CD8 alleles
was determined relative to pericentric heterochromatin do-
mains, as defined by 
 
  
 
satellite DNA (4). Alleles were clas-
sified either as not associated with 
 
  
 
satellite foci, as associ-
ated, or as constrained to the dark area surrounding the 
 
 
 
satellite domains, which appeared to exclude background
hybridization (Fig. 1 A). Based on previous work using 
 
 
 
satellite probes together with antibodies against nuclear
proteins, this area would correspond to pericentromeric
foci of Ikaros proteins (4, 6, 28). Distance measurements
from the center of locus-specific FISH signals to the nearest
 
  
 
satellite domain substantiated this classification (
 
 
 
0.8 
 
 
 
m
for “nonassociated,” 0.55–0.8 
 
 
 
m for “constrained,” and
 
 
 
0.55 
 
 
 
m for “associated” alleles; Fig. S1, available at http:
//www.jem.org/cgi/content/full/jem.20041127/DC1).
CD8 alleles were not spatially associated with centro-
meric heterochromatin in the great majority (
 
 
 
90%) of
MHC-naive (MHC
 
o/o
 
) DP thymocytes (
 
n 
 
  
 
284), or DP
 
hi
 
cells from class I–deficient and AND mice (83%, 
 
n 
 
  
 
100
and 91%, 
 
n 
 
  
 
200, respectively). In contrast, centromere-
associated or constrained CD8 alleles were recorded in 46%
of class I–deficient CD4 SP (
 
n 
 
  
 
101) and in 57% of AND
CD4 SP cells (
 
n 
 
  
 
111). Critically, centromeric reposition-
ing was already apparent in class II–selected transitional
thymocyte subsets: 38% of class I–deficient CD4
 
  
 
CD8
 
lo
 
(
 
n 
 
  
 
95) cells had constrained or 
 
  
 
satellite–associated CD8
alleles. In AND thymocytes, repositioning of CD8 alleles
was seen in DP
 
lo 
 
cells (42%, 
 
n 
 
  
 
201) as well as in CD4
 
 
 
CD8
 
lo 
 
cells (48%, 
 
n 
 
  
 
115; Fig. 1 B).
In contrast to CD8 alleles, CD4 alleles did not undergo
centromeric repositioning in developing AND thymocytes
(3% of DP
 
hi 
 
cells, 
 
n 
 
  
 
82; 6% of DP
 
lo 
 
cells, 
 
n 
 
  
 
101; 7% of
CD4
 
  
 
CD8
 
lo 
 
cells, 
 
n 
 
  
 
151; 6% of CD4 SP cells, 
 
n 
 
  
 
150;
Fig. 1 B), indicating that repositioning was selective for
CD8 during class II–driven thymocyte differentiation.
Centromeric repositioning of CD8 did not occur dur-
ing the development of thymocytes transgenic for the class
I–restricted OT-I TCR (7% of OT-I DP
 
hi
 
, 
 
n 
 
  
 
101; 7% of
CD4
 
  
 
CD8
 
lo
 
, 
 
n 
 
  
 
114; 6% of DP
 
lo
 
, 
 
n 
 
  
 
94; 10% of CD8
SP, 
 
n 
 
  
 
115; Fig. 1 B), which we examined as an example of
MHC class I–driven thymocyte differentiation. Instead, the
frequency of cells with constrained or 
 
  
 
satellite–associated
CD4 alleles, which was constant throughout MHC class II–
driven thymocyte differentiation, increased during OT-I dif-
ferentiation from 6% in DP
 
hi 
 
cells (
 
n 
 
  
 
150) to 20% in DP
 
lo
 
(
 
n 
 
  
 
100), and 21% in CD4  CD8lo cells (n   150) to 37%
in the CD8 SP (n   150; Fig. 1 B). Hence, repositioning of
CD4 in class I–selected OT-I thymocytes appeared less ex-
tensive than that of CD8 in class II–selected thymocytes, but
was initiated in transitional thymocyte subsets.
To further evaluate the selectivity of coreceptor locus re-
positioning during MHC class I– and II–driven thymocyte
differentiation, we examined the nuclear position of con-
trol loci. TCR  expression continues during the DP to SP
transition, and TCR  loci remained noncentromeric dur-
ing both MHC class I– and II–driven thymocyte differenti-
ation (we detected constrained or centromere-associated
TCR  loci in 17% of MHCo/o DPhi, n   103; 13% of class
II–selected [AND] CD4  CD8lo, n   109; and 2% of class
I–selected (A o/o) CD4  CD8lo, n   102; Fig. 2 A). In
contrast to TCR , expression of Tdt is terminated by
TCR signals at the DP stage (6, 7). Tdt was found in non-
centromeric positions in MHC-naive DPhi cells (15% of
MHCo/o DPhi cells had constrained or centromere-associ-
ated Tdt loci, n   106; Fig. 2 A) and was repositioned to
centromeric heterochromatin domains during both MHC
class I– and II–driven thymocyte differentiation (87% of
A o/o CD4  CD8lo,  n    102 and 92% of AND CD4 
CD8lo, n   60; Fig. 2 A).
In addition to centromeric repositioning, the shutdown of
coreceptor loci during thymocyte differentiation was accom-
Figure 2. Nuclear position of
control loci and the impact of heat
denaturation on the detection of
CD8 alleles during thymocyte de-
velopment. (A) MHCo/o  DPhi,
MHC class II–selected AND CD4 
CD8lo, and MHC class I–selected
CD4  CD8lo cells were isolated and
subjected to 3-D FISH using probes
for TCR , which is expressed
throughout the DP to SP transition,
and Tdt, which is silenced in the DP
to SP transition. (B) MHCo/o DPhi
and MHC class II–selected AND
CD4  CD8lo cells were isolated and
subjected to a modified FISH proto-
col including heat denaturation (refer
to Materials and Methods). This in-
creased the detection of centromere-
associated CD8 alleles in AND
CD4  CD8lo cells compared with 3-D
FISH data shown in B.CD4/CD8 Lineage Choice 1440
panied by a progressive reduction in locus accessibility to
FISH probes under 3-D FISH conditions (not depicted). This
was reflected in nonequivalent probe hybridization, which
was not due to technical failure because our probes worked
with  90% efficiency in DPhi cells (not depicted). To address
whether changes in locus accessibility resulted in an underes-
timate of the actual extent to which silenced coreceptor loci
were repositioned, we modified our FISH protocol to in-
clude heat denaturation. This compromised the preservation
of nuclear structure (not depicted), but improved the detec-
tion of CD8 alleles in AND CD4  CD8lo cells. Under these
conditions, we found centromere-associated CD8 alleles in
81% of AND CD4  CD8lo cells, compared with 48% by 3-D
FISH (Fig. 2 B). Hence, denaturation conditions that disrupt
protein–DNA interactions revealed previously undetectable
CD8 alleles in centromeric positions.
Developmental Potential of Transitional Thymocyte Subsets.
In parallel to evaluating the position of CD4 and CD8
coreceptor loci in the nucleus, we analyzed lineage com-
mitment and developmental potential of sorted thymocyte
subsets. Initial experiments suggested that coreceptor reex-
pression (14) was not necessarily indicative of lineage com-
mitment (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20041127/DC1) and we opted for re-
Figure 3. Lineage commitment and loss of CD8 lineage
potential during MHC class II–driven thymocyte differen-
tiation. (A) DPhi, DPlo, CD4  CD8lo, and CD4 SP thy-
mocyte subsets were isolated from MHC class I–deficient
(Tap1o/o) mice. (B) Isolated MHC class I–deficient thy-
mocyte subsets were cultured in reaggregates with MHCo/o
thymic stroma for the indicated number of hours and then
analyzed for CD4 and CD8 expression. (C) Isolated MHC
class I–deficient thymocyte subsets were cultured in re-
aggregates with MHCo/o thymic stroma in the presence of
anti-CD3/CD3 for 96 h. (D) Isolated MHC class I–deficient
thymocyte subsets were cultured in reaggregates with H2b
stroma for 96 h. (E) DPhi, DPlo, CD4  CD8lo, and CD4 SP
thymocyte subsets were isolated from AND TCR trans-
genic mice and cultured in reaggregates with MHCo/o thy-
mic stroma for 72 h.Merkenschlager et al. 1441
aggregate cultures with H2b thymic stroma (to allow for
sustained TCR–pMHC contact) or MHCo/o stroma (26).
The latter monitors the cells’ competence to differentiate
without pMHC contact. When combined with bispecific
CD3/CD4 or CD3/CD3 antibodies (27), which drive the
differentiation of uncommitted thymocytes to the CD4 or
the CD8 lineage, respectively (29), the system becomes a
powerful tool to probe thymocyte lineage potential.
DPhi CD69 , DPlo CD69 , CD4  CD8lo, and CD4
SP thymocyte populations were sorted from MHC class
I–deficient mice (Fig. 3 A) and subjected to reaggregate
culture. The CD4  CD8lo population readily generated
CD4 SP progeny in MHCo/o stroma (67   4% at 96 h, n   3;
Fig. 3 B) as well as a minor CD8 SP population (11   2%,
n   3). To further evaluate residual CD8 lineage potential,
we exposed CD4  CD8lo reaggregate cultures to bispecific
CD3/CD3 antibodies, which drive uncommitted thymo-
cytes to the CD8 lineage (29). The CD4 bias of the
CD4  CD8lo population was not reversed by anti-CD3/
CD3 (13   8% CD8 SP at 96 h, n   3), whereas DPhi cells
readily generated CD8 SP progeny under these conditions
(33   4% CD8 SP at 96 h, n   3; Fig. 3 C). For compari-
son, DPhi, DPlo, CD4  CD8lo, and CD4 SP thymocyte
populations were sorted from AND TCR (RAG-1o/o H2b)
transgenic mice and placed in MHCo/o reaggregates (Fig. 3
E). AND CD4  CD8lo differentiated to the CD4 SP stage
with similar efficiency as class I–deficient CD4  CD8lo
cells, without generating CD8 SP progeny (Fig. 3, com-
pare B with E). In this experimental system, the CD4 
CD8lo phenotype therefore marks a stage during MHC class
II–driven thymocyte differentiation at which cells appear
committed to the CD4 lineage and are able to progress
to the CD4 SP stage without further pMHC contact. As
demonstrated above for AND thymocytes, CD8 but not
Figure 4. Lineage commitment
and loss of CD4 lineage potential
during MHC class I–driven thy-
mocyte differentiation. (A) OT-I
TCR transgenic RAG-1o/o  H2b
thymocytes were isolated and
analyzed as described in Fig. 2 A.
(B) The generation of CD4 SP
(red), DP (blue), and CD8 SP
(green) progeny by MHCo/o and
OT-I thymocyte subsets is plotted
for control reaggregates with
MHCo/o stroma (left). Bispecific
CD3/CD4 antibodies were added
to drive the differentiation of un-
committed thymocytes to the
CD4 lineage (right). Cell cycle
analysis showed that the genera-
tion of CD4 SP progeny was not
due to the expansion of preexist-
ing cells (CD4  CD8lo in MHCo/o
stroma: G1   84.3%, S   2.3%,
G2/M     3.3%; CD4   CD8lo
with bispecific CD3/CD4: G1  
85.6%, S   2.8%, G2/M   2.4%,
not depicted). (C) CD4  CD8lo
and DPlo  subsets were isolated
from class II–deficient (A o/o)
mice and analyzed 24 and 48 h
after reaggregation with MHCo/o
stroma.CD4/CD8 Lineage Choice 1442
CD4 alleles are repositioned to centromeric heterochroma-
tin at this stage (Fig. 1 B).
In contrast to CD4  CD8lo cells, the class II–selected
DPlo population failed to progress to the CD4 SP stage
when deprived of pMHC. Most (77%) returned to a DPhi
phenotype within 24 h, whereas others were diverted to a
CD8 SP phenotype (5% at 24 h, 13% at 48 h, and 58% at
96 h; Fig. 3 B). CD8 differentiation of DPlo cells could not
be ascribed to residual MHC class I expression by class I–
( 2m or Tap1) deficient cells because a fraction of AND
TCR transgenic DPlo cells also became CD8 SP (5%; Fig.
3 E). The yields of CD8 SP progeny generated by class
I–deficient DPlo cells increased moderately (4.5-    2.1-
fold, n   4) in the presence of bispecific anti-CD3/CD3
(Fig. 3 C), and they generated CD8 SP (15%) as well as
CD4 SP (25%) progeny in reaggregates with H2b stroma
(Fig. 3 D). By these criteria and in this experimental sys-
tem, class II–selected DPlo cells are not uniformly or irre-
versibly CD4 committed. Nevertheless, CD8 alleles were
selectively repositioned to centromeric heterochromatin in
AND DPlo cells (Fig. 1 B).
Next, we examined DPhi, DPlo, CD4 8lo, and CD8 SP
subsets from OT-I TCR transgenic (RAG-1o/o H2b) mice
as an example for MHC class I–selected thymocytes. DPhi
cells generated relatively few CD8 SP progeny in MHCo/o
stroma (15   12% at 72–96 h, n   3), but efficiently differ-
entiated to the CD8 SP stage in H2b stroma (Fig. 4 A). We
were surprised by the behavior of DPlo cells, which we ex-
pected would up-regulate CD4 to become CD4  CD8lo
(12, 16). Only a minority of DPlo cells became CD4 
CD8lo (6% in MHCo/o, Fig. 3 A; 4% in H2b stroma, not de-
picted) or DPhi (14% in MHCo/o stroma, Fig. 4 A; 4% in
H2b stroma, not depicted). Instead, they quickly progressed
to the CD8 SP stage (45% at 24 h, 70% at 48 h, not de-
picted; 97% at 72 h, Fig. 4 A). Conversely, many CD4 
CD8lo cells became DPlo (44% at 24 h) and then progressed
to the CD8 SP stage (14% at 24 and 80% at 72 h, Fig. 4 A).
Consistent with residual CD4 potential (see below), CD4 
CD8lo but not DPlo cells reproducibly generated a minor
CD4 SP population (13   3%, n   7; Fig. 4 A).
These results tentatively placed DPlo downstream of CD4 
CD8lo cells, suggesting that the developmental sequence in
the OT-I thymus was reversed relative to that of MHC class
II–selected thymocytes (Fig. 3 A). Therefore, we examined
the developmental potential of OT-I thymocyte populations
in reaggregates exposed to bispecific CD3/CD4 antibodies,
which drive uncommitted thymocytes to the CD4 lineage
(reference 29 and Fig. 4 B). The CD4  CD8lo population
generated a much higher percentage of CD4 SP progeny
(61%) than the DPlo population (20%; cell cycle analysis con-
firmed that the increase of CD4 SP was due to differentia-
tion, not expansion of preexisting cells; see legend to Fig. 4
B for details). Hence, in contrast to class II–selected CD4 
CD8lo cells (Fig. 3 A), the OT-I CD4  CD8lo subset appears
flexible in its lineage choice. Progressive CD8 lineage com-
mitment and the loss of developmental potential for the
CD4 lineage place OT-I thymocyte populations in the fol-
lowing order: DPhi   CD4  CD8lo   DPlo   CD8 SP. To
test whether this applies to MHC class I–selected thy-
mocytes in general, we isolated CD4  CD8lo and DPlo sub-
sets from MHC class II–deficient (A o/o) mice. DPlo cells
differentiated to the CD8 SP stage within 24 (36%) to 48 h
(64%) and generated few CD4  CD8lo or DPhi progeny (Fig.
4 C). CD4  CD8lo cells became DPlo (75% at 24 h) en route
to the CD8 SP stage (81% at 48 h; Fig. 4 C). These data
confirm that in our experimental system, the majority of
class I–selected DPlo cells behave as progeny, not precursors
of CD4  CD8lo cells.
Discussion
Coreceptor Locus Repositioning Is Predictive of CD4/CD8
Lineage Choice. 3-D FISH analysis revealed marked cen-
tromeric association of CD8 loci increased in MHC class
II–selected CD4  CD8lo populations, coincident with the
cells’ ability to differentiate to the CD4 SP stage without
continued pMHC contact, and with their reduced poten-
tial to differentiate toward the CD8 lineage in response to
anti-CD3/CD3. In AND TCR transgenic thymocytes,
substantial centromeric association of CD8 occurred at the
earlier DPlo stage, suggesting that for this TCR specificity at
least, CD8 repositioning precedes the ability to differentiate
to the CD4 lineage without further pMHC signals. Analy-
sis of OT-I TCR transgenic cells as an example of class
I–selected thymocytes indicates that the CD4 locus is repo-
sitioned during the differentiation to the CD8 (not the
CD4) lineage, if to a lesser extent than CD8 in CD4-com-
mitted cells. Robust repositioning of CD4 during CD8 T
cell differentiation has been seen in other models of CD8 T
cell differentiation (Robey, E., personal communication).
Hence, in contrast to CD4/CD8 protein and RNA expres-
sion, locus repositioning appears to be predictive of lineage
choice before differentiation to the SP stage.
Functional Nonequivalence of MHC Class I– and II–selected
Transitional Thymocyte Populations. Coreceptor locus re-
positioning and differential accessibility demonstrates that
transitional thymocyte subsets selected by MHC class I and
II are not equivalent, a conclusion that is substantiated by
the functional analysis of their developmental potential.
First, in contrast to class I–selected DPlo cells, which reach
the CD4 SP stage independently of stroma pMHC, class
II–selected DPlo cells need pMHC to become CD4 SP in
our experimental system. They are not uniformly CD4
committed and can generate CD8 SP progeny when de-
prived of pMHC or exposed to bispecific anti-CD3/CD3.
Second, class II–selected CD4  CD8lo become CD4 SP
without pMHC and appear largely CD4 committed be-
cause they are not readily redirected to the CD8 lineage by
anti-CD3/CD3. Class I–selected CD4  CD8lo cells also
differentiate to the SP stage in MHCo/o stroma, but in con-
trast to their class II–selected counterparts, they are not
uniformly or irreversibly lineage committed and can be re-
directed to the CD4 lineage by bi-specific antibodies. Be-
cause it takes 24 h for MHC-naive OT-I cells to become
CD4  CD8lo when placed in a selecting environment (not
depicted), CD8 lineage commitment appears to be a pro-Merkenschlager et al. 1443
tracted process, which can be overridden for many hours
after initial pMHC contact. Finally, MHC class I– and II–
selected transitional thymocytes appear to differ with re-
spect to developmental sequence. Our analysis agrees with
models that place DPlo cells between the DPhi and the
CD4  CD8lo population (12–16) in MHC class II–driven
differentiation. However, three lines of evidence place the
majority of class I–selected DPlo cells firmly downstream
of CD4  CD8lo: (a) class I–selected DPlo cells transit to
the CD8 SP stage faster than CD4  CD8lo cells; (b) class
I–selected CD4  CD8lo cells transit through a DPlo stage en
route to the CD8 SP stage, but not vice versa; and (c) class
I–selected DPlo cells lack CD4 lineage potential in our as-
say, in contrast to CD4  CD8lo cells. This does not exclude
that some MHC class I–selected thymocytes transit through
a DPlo stage before they become CD4  CD8lo (16).
Implications for Models of CD4/CD8 Lineage Commitment.
We find that CD8 locus repositioning is indicative of the
fate of CD4-committed CD4  CD8lo thymocytes before
their differentiation to the SP stage and may precede com-
mitment and/or the competence of MHC class II–signaled
DPlo cells to differentiate to the CD4 lineage without fur-
ther pMHC contact. These data provide novel markers (30–
33) of thymocyte lineage choice before overt differentiation
and contribute to a growing body of evidence against purely
stochastic/selective models of CD4/CD8 lineage commit-
ment (for review see reference 12). Our functional data in-
dicate that MHC class I–selected CD4  CD8lo thymocytes
are competent to progress toward the CD8 lineage, yet re-
tain CD4 lineage potential. This calls into question the con-
ceptual distinction between instructive and stochastic/selec-
tive models of lineage choice. It adds to evidence (for
review see reference 12) that the CD4/CD8 cell fate deci-
sion can be iterative and is not necessarily made “on the
spot” as had been implied in the original models. Taken to-
gether with data that the specification of CD4 lineage fate is
initially labile (as predicted by kinetic signaling models; ref-
erences 12, 33, and 34), but becomes firmly specified within
hours (34), and evidence that CD4 lineage specification is
promoted by signal strength/lck activity (12, 29, 35), one
could liken thymocyte lineage choice to an auction where
thymocytes will firmly accept a “CD4 bid” within a few
hours, whereas cells receiving “CD8 bids” may remain
open to higher offers (and a CD4 lineage fate) for an ex-
tended period. At a mechanistic level, a cascade of chroma-
tin-based events, including repositioning of coreceptors and
other silenced loci (7), would ultimately result in lineage
progression. The lineage-specific reorganization of the thy-
mocyte nucleus opens new avenues for investigating the
molecular basis of lineage choice.
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